Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2023-04-13 Purchase |
2023-04-14 06:00 am |
Oncternal Therapeutics Inc. | ONCT | VINCENT RICHARD G Chief Financial Officer |
30,000 | $0.2987 | $8,961 | 163,219 (Indirect Direct) |
View |
| 2022-03-24 Purchase |
2022-03-28 4:00 pm |
Oncternal Therapeutics Inc. | ONCT | VINCENT RICHARD G Chief Financial Officer |
5,000 | $1.4421 | $7,210 | 94,522 (Indirect Direct) |
View |
| 2022-01-27 Purchase |
2022-01-31 4:00 pm |
Oncternal Therapeutics Inc. | ONCT | VINCENT RICHARD G Chief Financial Officer |
12,500 | $1.73 | $21,625 | 89,522 (Indirect Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-03-20 Option Award |
2025-03-21 4:50 pm |
N/A 2035-03-20 |
Forte Biosciences Inc. | FBRX | VINCENT RICHARD G Director |
31,000 | $0 | 31,000 (Direct) |
View |
| 2024-09-17 Option Award |
2024-09-19 6:30 pm |
N/A 2034-09-17 |
Forte Biosciences Inc. | FBRX | VINCENT RICHARD G Director |
2,000 | $0 | 2,000 (Direct) |
View |
| 2024-02-14 Option Award |
2024-02-15 6:00 pm |
N/A 2034-02-14 |
Oncternal Therapeutics Inc. | ONCT | VINCENT RICHARD G Chief Financial Officer |
14,200 | $0 | 14,200 (Direct) |
View |
| 2024-01-03 Tax Withholding |
2024-01-05 4:00 pm |
N/A N/A |
Oncternal Therapeutics Inc. | ONCT | VINCENT RICHARD G Chief Financial Officer |
8,868 | $0.4961 | 147,282 (Direct) |
View |
| 2023-10-02 Option Award |
2023-10-04 4:59 pm |
N/A 2029-09-12 |
Oncternal Therapeutics Inc. | ONCT | VINCENT RICHARD G Chief Financial Officer |
738,467 | $0 | 738,467 (Direct) |
View |
| 2023-07-03 Tax Withholding |
2023-07-05 6:58 pm |
N/A N/A |
Oncternal Therapeutics Inc. | ONCT | VINCENT RICHARD G Chief Financial Officer |
7,069 | $0.36 | 156,150 (Direct) |
View |
| 2023-02-21 Option Award |
2023-02-23 8:00 pm |
N/A 2033-02-21 |
Oncternal Therapeutics Inc. | ONCT | VINCENT RICHARD G Chief Financial Officer |
210,000 | $0 | 210,000 (Direct) |
View |
| 2023-01-03 Tax Withholding |
2023-01-05 6:00 pm |
N/A N/A |
Oncternal Therapeutics Inc. | ONCT | VINCENT RICHARD G Chief Financial Officer |
4,428 | $1.02 | 133,219 (Direct) |
View |
| 2022-07-28 Option Award |
2022-08-01 6:19 pm |
N/A 2032-07-28 |
Oncternal Therapeutics Inc. | ONCT | VINCENT RICHARD G Chief Financial Officer |
71,875 | $0 | 166,397 (Direct) |
View |
| 2022-01-20 Option Award |
2022-01-24 4:00 pm |
N/A 2032-01-20 |
Oncternal Therapeutics Inc. | ONCT | VINCENT RICHARD G Chief Financial Officer |
109,579 | $0 | 109,579 (Direct) |
View |
| 2022-01-03 Option Award |
2022-01-05 7:00 pm |
N/A N/A |
Oncternal Therapeutics Inc. | ONCT | VINCENT RICHARD G Chief Financial Officer |
29,867 | $0 | 77,022 (Direct) |
View |
| 2021-02-11 Option Award |
2021-02-16 6:00 pm |
N/A 2031-02-11 |
Oncternal Therapeutics Inc. | ONCT | VINCENT RICHARD G Chief Financial Officer |
280,000 | $0 | 280,000 (Direct) |
View |